Genomics & pharmacogenomics – Your questions answered

Expert/s: Dr Alan Ma
   Rated 5 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

1 hours

These are activities that use your work data to ensure quality results.

EA
0.5 hours

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 hours

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
1 hours

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

The questions answered in this podcast are listed below.
They were compiled by GPs and professional attendees at our face-to-face seminars around Australia.

  1. When is genomic testing Medicare-funded?
  2. What role and responsibilities does a GP have in pre-conception genomic counselling?
  3. How should thalassaemia screening be managed outside family planning settings?
  4. How should a GP decide whether to refer to a clinical geneticist or order first-tier genomic testing?
  5. How useful are polygenic risk scores for assessing chronic disease risk in general practice?
  6. How should a GP interpret and action discordant or inconclusive results from a multi-gene pharmacogenomics panel?
  7. How should a GP manage a patient who presents with direct-to-consumer genetic test results suggesting a high disease risk?
  8. What is the role of pharmacogenomics in general practice?
  9. How often should pharmacogenomic testing be repeated?
  10. What genomic resources should GPs use for self-education?

 
Expert: Dr Alan Ma, Clinical Geneticist

Host: A/Prof Ralph Audehm, GP & Medical Educator

Total time: 32 mins
 
Recommended resources

 

Last Updated: 21 Oct, 2026

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Paige Lanyon-Roberts

Dr Paige Lanyon-Roberts

The New Oral Medications for Obesity – A Practical Guide for GPs

Dr Terri-Lynne South

Dr Terri-Lynne South

Oral GLP1s – What GPs Need to Know

Dr Katherine Spira

Dr Katherine Spira

Menstrual Migraine

Prof Danny Green

Prof Danny Green

GLP1s and Muscle Mass – What Does the Evidence Show?

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Alan Ma

expert

Dr Alan Ma

Clinical Geneticist; Department of Clinical Genetics, Sydney Children's Hospitals Network; Senior Lecturer, Specialty of Genomic Medicine, University of Sydney

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.